Lonza · 7 hours ago
MSAT Process Technical Writer
Lonza is a global leader in life sciences, committed to manufacturing the medicines of tomorrow. They are seeking an MSAT Process Technical Writer who will be responsible for delivering high-quality process Batch Records for various customer projects, ensuring accuracy and timely editing of cGMP documents.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Edit documents: Review and template documents with accurate, clear, and explicit description and justifications
Manage document revision: Perform initial review for scope, attain signoffs and justifications, set up review meetings, etc
Manage document comments: Answer and translate questions into the reviewed document to meet regulatory, internal, and external requirements with the aid of document owners
Maintain and review schedules/campaigns: Manage document timelines to support the manufacturing schedule; communicate and escalate appropriately to maintain document timelines
Qualification
Required
Bachelor's degree required
Working experience of pharma/biotech (or equivalent)
Technical writing in the biotech industry
Project management skills
Strong MS Word experience
Preferred
Bachelor's degree in Scientific related field
Working experience of pharma/biotech (or equivalent)
Technical writing in the biotech industry
Project management skills a plus
Strong MS Word experience preferred
Benefits
Competitive compensation and benefits package.
401(k) matching plan.
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
NH Business Review
2026-01-17
Company data provided by crunchbase